C5VP001A
Cellicon® Filter Assembly with Durapore® Membrane
filtration area 0.01 m2
Synonym(s):
Cellicon® Perfusion Filter with Durapore® Membrane
Select a Size
$3,690.00
$3,690.00
About This Item
Skip To
material
PET support
PVDF
polyester support
Quality Level
Agency
meets USP Biological Reactivity Test for class VI plastics (family component materials)
sterility
sterile; γ-irradiated (level of 25-40kGy)
flow rate measuring range
10 L/min (/m2)
parameter
1 psi max. reverse press. exposure at 25 °C
1-2.5 L process volume
15 psi at 25 °C (max. burst pressure)
5 psi max. inlet pressure at 25 °C
filtration area
0.01 m2
membrane filtration area
0.01 m2
pore size
5 μm pore size
storage temp.
15-25°C
Looking for similar products? Visit Product Comparison Guide
1 of 4
This Item | PXDVPPC50 | PXVVPPC50 | PXHVMPC50 |
|---|---|---|---|
| pore size 5 μm pore size | pore size 0.65 μm nominal pore size, 0.65 μm pore size | pore size 0.1 μm nominal pore size, 0.1 μm pore size | pore size 0.45 μm nominal pore size, 0.45 μm pore size |
| filtration area 0.01 m2 | filtration area 50 cm2 | filtration area 50 cm2 | filtration area 50 cm2 |
| material PET support, polyester support, PVDF | material PVDF membrane, polypropylene , polypropylene screen | material PVDF membrane, polypropylene , polypropylene screen | material PVDF membrane, polypropylene , polypropylene screen |
| sterility sterile; γ-irradiated (level of 25-40kGy) | sterility - | sterility - | sterility - |
| parameter 1 psi max. reverse press. exposure at 25 °C, 15 psi at 25 °C (max. burst pressure) | parameter 0.03-0.05 L/min recirculation rate, 15 mL min. working volume, 2.8 bar max. transmembrane pressure (40 psig), 5.5 bar max. inlet pressure (80 psi) at 50 °C | parameter 0.03–0.05 L/min recirculation rate, 15 mL min. working volume, 2.8 bar max. transmembrane pressure (40 psig), 5.5 bar max. inlet pressure (80 psi) at 50 °C | parameter 0.03–0.05 L/min recirculation rate, 15 mL min. working volume, 2.8 bar max. transmembrane pressure (40 psig), 5.5 bar max. inlet pressure (80 psi) at 50 °C |
| agency meets USP Biological Reactivity Test for class VI plastics (family component materials) | agency - | agency - | agency - |
General description
Application
Seed Train Perfusion
Features and Benefits
Other Notes
Legal Information
consumable
related product
Stay compliant with GMP using the Emprove® Program
Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.
Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.
Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite
Not finding what you are looking for? Visit the Emprove® Program Help page.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
How the Cellicon® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.
Before adoption of single-use technologies in biomanufacturing, manufacturers must assess the risk to the drug product from potential leachables. This article highlights a general approach based on the United States Pharmacopeia (USP).
Cellvento 4CHO-X Expansion Medium enhances cell biomass for bioreactor inoculation in cell expansion stages.
This page describes the financial and operational advantages offered by the Cellicon® Cell Retention Device in an N-1 perfusion process at the 2,000 L scale in comparison to a cell retention device from another supplier.
Related Content
En savoir plus sur la production en bioréacteur mAB et sur les produits nécessaires à cette étape.
Learn more on mAB bioreactor production, and the products you need for this step.
Les développeurs biopharmaceutiques ont besoin de procédés upstream qui soient efficaces et productifs afin de produire des anticorps monoclonaux (mAbs) et d'autres types de protéines recombinantes de haute qualité. L'intensification des procédés permet d'assurer la pérennité de leurs stratégies de fabrication, de réduire les coûts et d'accroître la polyvalence de leurs installations.
Les développeurs biopharmaceutiques ont besoin de procédés upstream qui soient efficaces et productifs afin de produire des anticorps monoclonaux (mAbs) et d'autres types de protéines recombinantes de haute qualité. L'intensification des procédés permet d'assurer la pérennité de leurs stratégies de fabrication, de réduire les coûts et d'accroître la polyvalence de leurs installations.
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service